ProPhase Labs (PRPH): ערך חשבונאי של החברה

This daily price chart for ProPhase Labs, Inc. (PRPH) on the GURU.Markets platform currently shows a level of 0.01. ProPhase Labs, Inc. (PRPH) generates revenue through laboratory diagnostics and the sale of vitamin dietary supplements. The holding company is integrating neural networks into gene sequencing, focusing on early cancer diagnostics. Now in its maturity phase, the business is expanding into pharmaceuticals and genomics to reduce its reliance on previous PCR tests.

ProPhase Labs, Inc. (PRPH) business depends on demand volatility for diagnostics and the development of the nutraceuticals segment, which necessitates strict cost control. The current value of 0.01 reflects the difference between all assets and liabilities, where monitoring the dynamics of balance sheet capitalization allows for an assessment of real equity growth and the risk of inefficient resource utilization as pandemic-related revenues decline.